Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger and SPRY domain-containing protein 1 (RSPRY1) is a glycoprotein encoded by the RSPRY1 gene, characterized by the presence of a RING-type zinc finger domain—which is often associated with E3 ubiquitin ligase activity—and a SPRY domain of currently unknown specific function[1][3][5][7]. The physiological function of RSPRY1 is not fully understood, but current evidence links the protein to bone development, and pathogenic mutations cause spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, an autosomal recessive skeletal disorder[5][9]. No drugs are currently known to interact with RSPRY1, nor is it recognized as a validated therapeutic target in disease[1][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger and SPRY domain-containing protein 1 (RSPRY1).